Efficacy and tolerability of the pharmaconutraceutical complex Theraflex Ultra in the treatment of patients with chronic non-specific lower back pain due toprimarily discogenic pathology (FORSAGE study)
Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(5):108-114. doi: 10.17116/jnevro2026126051108.ABSTRACTOBJECTIVE: To evaluate the efficacy and tolerability of the pharmaconutraceutical complex, Theraflex Ultra, based on undenatured (native) type II collagen, in the treatment of discogenic chronic low back pain (CLBP).MATERIAL AND METHODS: This open, multicenter, observational study included 50 patie
June 5, 2026